Skip to main content

Table 4 Number of patients receiving P. aeruginosa relevant antibiotics (ITT population)

From: A randomized placebo-controlled phase II study of a Pseudomonas vaccine in ventilated ICU patients

  IC43 100 µg with adj(N = 104) No. (%) IC43 100 µg w/o adj(N = 98) No. (%) IC43 200 µg with adj(N = 101) No. (%) Placebo(N = 98) No. (%) Total(N = 401) No. (%)
Subjects with at least one P. aeruginosa relevant antibiotics during the study 84 (80.8) 76 (77.6) 84 (83.2) 83 (84.7) 327 (81.5)
  1. ITT intention-to-treat; w/o adj without aluminium hydroxide adjuvant; with adj with aluminium hydroxide adjuvant